- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06471166
The Effect of Different Treatment Modalities of Tubal Ectopic Pregnancy on Ovarian Reserve: a Prospective Cohort Study
June 18, 2024 updated by: Andro Bahgat Heshmat, Assiut University
Detect the effect of different treatment modalities of tubal ectopic pregnancy on ovarian reserve
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
90
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Andro Bahgat, MD
- Phone Number: 01283104773
- Email: androbahgat7@gmail.com
Study Locations
-
-
-
Assiut, Egypt
- Recruiting
- Assiut University
-
Contact:
- Andro Bahgat, Md
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
Women's Health Hospital, Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University
Description
Inclusion Criteria:
- The study will include patients aged 18-44 years with known diagnosis or suspicion of diagnosis of tubal ectopic pregnancy (abnormal doubling rates of their b-HCG levels as well as ultrasonographically identified or unidentified gestational sacs outside the uterus)
- Included patients must have capacity to provide informed consent. Given the potential emergent nature of presentation, women will not be recruited if fully informed consent could be compromised due to a highly distressed emotional state or significant hemorrhage necessitating the need for urgent surgery
Exclusion Criteria:
- The use of hormonal contraceptives within two months of enrolment
- If other surgery was conducted at the time of salpingectomy.
- If a woman was pregnant at follow up visit for AMH measurement
- History of previous surgeries of fallopian tubes and/or ovaries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Conservative management
|
Ovarian reserve
|
|
Medical treatment
|
Ovarian reserve
|
|
Surgical treatment (Open or laparoscopic salpingectomy)
|
Ovarian reserve
|
|
Surgical treatment after failed medical treatment (Open or laparoscopic salpingectomy)
|
Ovarian reserve
|
|
Conservative surgical treatment (salpingotomy, salpingostomy, tubal milking)
|
Ovarian reserve
|
|
Conservative surgical treatment after failed medical treatment
|
Ovarian reserve
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in levels of AMH pre and post treatment
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 10, 2024
Primary Completion (Estimated)
October 1, 2025
Study Completion (Estimated)
October 10, 2025
Study Registration Dates
First Submitted
June 18, 2024
First Submitted That Met QC Criteria
June 18, 2024
First Posted (Actual)
June 24, 2024
Study Record Updates
Last Update Posted (Actual)
June 24, 2024
Last Update Submitted That Met QC Criteria
June 18, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Arrhythmias, Cardiac
- Cardiac Conduction System Disease
- Pregnancy Complications
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Pregnancy, Ectopic
- Cardiac Complexes, Premature
- Pregnancy, Tubal
- Physiological Effects of Drugs
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones
Other Study ID Numbers
- Ectopic pregnancy
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.